{
  "id": "resp_08d4dc238d9da31200693c941e254c8195892e0482407c5647",
  "object": "response",
  "created_at": 1765577758,
  "status": "completed",
  "background": false,
  "billing": {
    "payer": "developer"
  },
  "error": null,
  "incomplete_details": null,
  "instructions": null,
  "max_output_tokens": null,
  "max_tool_calls": null,
  "model": "gpt-5.2-2025-12-11",
  "output": [
    {
      "id": "rs_08d4dc238d9da31200693c941e77b08195844abc055adc58bb",
      "type": "reasoning",
      "summary": []
    },
    {
      "id": "ws_08d4dc238d9da31200693c942573e88195857fe4e5c4b9a57f",
      "type": "web_search_call",
      "status": "completed",
      "action": {
        "type": "search",
        "query": "\"covalent inhibitor\" CDK12 CDK13 triple negative breast cancer"
      }
    },
    {
      "id": "rs_08d4dc238d9da31200693c9426e8108195886b2f61b968a5d5",
      "type": "reasoning",
      "summary": []
    },
    {
      "id": "ws_08d4dc238d9da31200693c943ea1a08195a2e3da3be9676ebb",
      "type": "web_search_call",
      "status": "completed",
      "action": {
        "type": "search",
        "query": "CDK12 covalent inhibitor drug candidate"
      }
    },
    {
      "id": "rs_08d4dc238d9da31200693c94403f408195a1d6896a4a6e6729",
      "type": "reasoning",
      "summary": []
    },
    {
      "id": "ws_08d4dc238d9da31200693c9449e6088195ada3d68b52a3e038",
      "type": "web_search_call",
      "status": "completed",
      "action": {
        "type": "search",
        "query": "ISM9274 CDK12/13 covalent inhibitor Insilico Medicine preclinical candidate geography"
      }
    },
    {
      "id": "rs_08d4dc238d9da31200693c944cddc48195a509a003a95fb08d",
      "type": "reasoning",
      "summary": []
    },
    {
      "id": "msg_08d4dc238d9da31200693c945ff960819588af484e4ccffdaf",
      "type": "message",
      "status": "completed",
      "content": [
        {
          "type": "output_text",
          "annotations": [],
          "logprobs": [],
          "text": "{\n  \"validated\": false,\n  \"assets\": [],\n  \"rejected_reason\": \"Candidate identifier \\\"covalent inhibitor\\\" is a generic descriptor, not a unique drug asset name/code. Web results show multiple distinct CDK12/13 covalent inhibitors (e.g., THZ531 https://pubmed.ncbi.nlm.nih.gov/27571479/; ISM9274 https://www.eurekalert.org/news-releases/1004993), so sponsor/target/modality/indication/stage/geography cannot be uniquely attributed to the candidate.\"\n}"
        }
      ],
      "role": "assistant"
    }
  ],
  "parallel_tool_calls": true,
  "previous_response_id": null,
  "prompt_cache_key": null,
  "prompt_cache_retention": null,
  "reasoning": {
    "effort": "xhigh",
    "summary": null
  },
  "safety_identifier": null,
  "service_tier": "default",
  "store": true,
  "temperature": 1.0,
  "text": {
    "format": {
      "type": "text"
    },
    "verbosity": "medium"
  },
  "tool_choice": "auto",
  "tools": [
    {
      "type": "web_search",
      "filters": null,
      "search_context_size": "medium",
      "user_location": {
        "type": "approximate",
        "city": null,
        "country": "US",
        "region": null,
        "timezone": null
      }
    }
  ],
  "top_logprobs": 0,
  "top_p": 0.98,
  "truncation": "disabled",
  "usage": {
    "input_tokens": 20289,
    "input_tokens_details": {
      "cached_tokens": 0
    },
    "output_tokens": 6023,
    "output_tokens_details": {
      "reasoning_tokens": 5899
    },
    "total_tokens": 26312
  },
  "user": null,
  "metadata": {}
}